by | May 28, 2024 | Publications
Ann Hematol. 2024 May 28. doi: 10.1007/s00277-024-05811-y. Online ahead of print. ABSTRACT Myeloma with extramedullary plasmacytomas not adjacent to bone (EMP) is associated with an extremely poor outcome compared with paraosseous plasmacytomas (PP) as current...
by | May 28, 2024 | Publications
Blood Adv. 2024 May 28;8(10):2573-2574. doi: 10.1182/bloodadvances.2024012705. NO ABSTRACT PMID:38805218 | DOI:10.1182/bloodadvances.2024012705
by | May 28, 2024 | Publications
J Clin Apher. 2024 Jun;39(3):e22127. doi: 10.1002/jca.22127. ABSTRACT BACKGROUND: Increasing indications for cellular therapy collections have stressed our healthcare system, with autologous collections having a longer than desired wait time until apheresis...
by | May 28, 2024 | Publications
Ren Fail. 2024 Dec;46(1):2356708. doi: 10.1080/0886022X.2024.2356708. Epub 2024 May 27. ABSTRACT As no unified treatment protocol or evidence yet exists for plasmapheresis without plasma, this study explored the outcomes of using 4% human albumin (ALB) solution as a...
by | May 28, 2024 | Publications
Acta Biochim Biophys Sin (Shanghai). 2024 May 27. doi: 10.3724/abbs.2024077. Online ahead of print. ABSTRACT Epigenetic modifications play an important role in cellular senescence, and enhancer of zeste homolog 2 (EZH2) is a key methyltransferase involved in...
by | May 28, 2024 | Publications
Blood Cancer J. 2024 May 27;14(1):84. doi: 10.1038/s41408-024-01048-0. ABSTRACT Despite being the mainstay of management for cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS), there is limited data regarding the impact...
